Woodline Partners’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.59M	Hold	195,033	–	–	0.02%	673
2025 Q4	$5.66M	Sell	195,033 -119,586	-38%	-$3.06M	0.02%	599
2025 Q3	$5.93M	Buy	314,619 +109,109	+53%	+$1.72M	0.03%	536
2025 Q2	$2.88M	Sell	205,510 -204,490	-50%	-$2.87M	0.02%	665
2025 Q1	$6.41M	Buy	+410,000	New	+$5.78M	0.04%	444
2023 Q4	–	Sell	-1,104,244	Closed	-$5.86M	–	483
2023 Q3	$5.86M	Buy	1,104,244 +296,494	+37%	+$2.52M	0.07%	298
2023 Q2	$7.7M	Buy	807,750 +112,075	+16%	+$1.24M	0.09%	241
2023 Q1	$7.65M	Buy	695,675 +50,776	+8%	+$735K	0.11%	236
2022 Q4	$9.54M	Buy	644,899 +94,503	+17%	+$1.65M	0.13%	219
2022 Q3	$10.5M	Buy	+550,396	New	+$12.5M	0.15%	195